BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34364401)

  • 1. Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.
    Parma B; Ramesh V; Gollavilli PN; Siddiqui A; Pinna L; Schwab A; Marschall S; Zhang S; Pilarsky C; Napoli F; Volante M; Urbanczyk S; Mielenz D; Schrøder HD; Stemmler M; Wurdak H; Ceppi P
    J Exp Clin Cancer Res; 2021 Aug; 40(1):248. PubMed ID: 34364401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.
    Polson ES; Kuchler VB; Abbosh C; Ross EM; Mathew RK; Beard HA; da Silva B; Holding AN; Ballereau S; Chuntharpursat-Bon E; Williams J; Griffiths HBS; Shao H; Patel A; Davies AJ; Droop A; Chumas P; Short SC; Lorger M; Gestwicki JE; Roberts LD; Bon RS; Allison SJ; Zhu S; Markowetz F; Wurdak H
    Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients.
    Tang Y; Yang Y; Luo J; Liu S; Zhan Y; Zang H; Zheng H; Zhang Y; Feng J; Fan S; Wen Q
    Cancer Biomark; 2021; 30(1):85-94. PubMed ID: 32986659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins.
    Parma B; Wurdak H; Ceppi P
    Drug Resist Updat; 2022 Dec; 65():100888. PubMed ID: 36332495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM).
    Duan Y; Yu J; Chen M; Lu Q; Ning F; Gan X; Liu H; Ye Y; Lu S; Lash GE
    J Ovarian Res; 2023 Apr; 16(1):81. PubMed ID: 37087461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential association of HSPD1 with dysregulations in ribosome biogenesis and immune cell infiltration in lung adenocarcinoma: An integrated bioinformatic approach.
    Aluksanasuwan S; Somsuan K; Ngoenkam J; Chutipongtanate S; Pongcharoen S
    Cancer Biomark; 2024; 39(3):155-170. PubMed ID: 37694354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated cardiomyopathy-linked heat shock protein family D member 1 mutations cause up-regulation of reactive oxygen species and autophagy through mitochondrial dysfunction.
    Enomoto H; Mittal N; Inomata T; Arimura T; Izumi T; Kimura A; Fukuda K; Makino S
    Cardiovasc Res; 2021 Mar; 117(4):1118-1131. PubMed ID: 32520982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.
    Qi M; Dai D; Liu J; Li Z; Liang P; Wang Y; Cheng L; Zhan Y; An Z; Song Y; Yang Y; Yan X; Xiao H; Shao H
    Oncogene; 2020 Mar; 39(13):2707-2723. PubMed ID: 32005973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
    Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
    BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 11. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.
    Kim SK; Kim K; Ryu JW; Ryu TY; Lim JH; Oh JH; Min JK; Jung CR; Hamamoto R; Son MY; Kim DS; Cho HS
    Int J Oncol; 2019 Jan; 54(1):65-76. PubMed ID: 30365075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
    Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
    Riccardo F; Arigoni M; Buson G; Zago E; Iezzi M; Longo D; Carrara M; Fiore A; Nuzzo S; Bicciato S; Nanni P; Landuzzi L; Cavallo F; Calogero R; Quaglino E
    BMC Genomics; 2014; 15 Suppl 3(Suppl 3):S1. PubMed ID: 25077564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
    Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
    Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
    Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
    J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.
    Liu X; Li C; Yang Y; Liu X; Li R; Zhang M; Yin Y; Qu Y
    EBioMedicine; 2019 Aug; 46():42-53. PubMed ID: 31395502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.